These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15921101)

  • 1. [Public drug marketing scrutinized by IGM and NBL. Conviction in four cases].
    Perman E
    Lakartidningen; 2005 Apr 18-24; 102(16):1262. PubMed ID: 15921101
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prohibited marketing and shift in meaning of indications--a case for the IGM].
    Perman E
    Lakartidningen; 2003 Jul; 100(28-29):2378-9. PubMed ID: 12899031
    [No Abstract]   [Full Text] [Related]  

  • 3. Advertising medicines to the public.
    George CF
    J R Coll Physicians Lond; 1996; 30(2):102-3. PubMed ID: 8709051
    [No Abstract]   [Full Text] [Related]  

  • 4. A defense of the learned intermediary doctrine.
    Goetz RB; Growdon KR
    Food Drug Law J; 2008; 63(2):421-38. PubMed ID: 18561470
    [No Abstract]   [Full Text] [Related]  

  • 5. [Failing quality of verbal drug advertising].
    Madsen S; Jerkø B
    Tidsskr Nor Laegeforen; 2015 Jan; 135(2):110-1. PubMed ID: 25625984
    [No Abstract]   [Full Text] [Related]  

  • 6. [Is household-targeted Gardasil advertising in accordance with the intentions of the legislators?].
    Linnersten L
    Lakartidningen; 2008 Jul 23-Aug 5; 105(30-31):2121. PubMed ID: 18751457
    [No Abstract]   [Full Text] [Related]  

  • 7. [Physicians report verbal drug information. Cases scrutinized by the IGM].
    Perman E
    Lakartidningen; 2004 Aug; 101(35):2648, 2650. PubMed ID: 15458219
    [No Abstract]   [Full Text] [Related]  

  • 8. Taming the tigers: the case for controlling the tobacco market.
    Borland R
    Addiction; 2004 May; 99(5):529-31. PubMed ID: 15078226
    [No Abstract]   [Full Text] [Related]  

  • 9. [Reporting by the IGM (Information Inspection Team). Marketing of Clarityn disguised as an inquiry].
    Lakartidningen; 1996 Sep; 93(37):3168. PubMed ID: 8847942
    [No Abstract]   [Full Text] [Related]  

  • 10. [Physicians' travels abroad supported by drug industry scrutinized. Three cases surveyed by the IGM and the NBL].
    Perman E
    Lakartidningen; 2003 Dec; 100(51-52):4298-9. PubMed ID: 14756095
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug marketing: nonfederal regulation.
    Skinner WJ
    Hosp Formul; 1978 Nov; 13(11):911-2, 915-6, 918. PubMed ID: 10239345
    [No Abstract]   [Full Text] [Related]  

  • 12. Defining commercial speech in the context of food marketing.
    Pomeranz JL; Adler S
    J Law Med Ethics; 2015; 43 Suppl 1():40-3. PubMed ID: 25846162
    [No Abstract]   [Full Text] [Related]  

  • 13. Self-regulation and the response to concerns about food and beverage marketing to children in the United States.
    Wilde P
    Nutr Rev; 2009 Mar; 67(3):155-66. PubMed ID: 19239630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Can we rely on drug information?].
    Myhr K
    Tidsskr Nor Laegeforen; 2002 Nov; 122(27):2644-6. PubMed ID: 12523198
    [No Abstract]   [Full Text] [Related]  

  • 15. [Unacceptable aggressive marketing].
    Eldrup J; Gerstenberg TC; Hald T; Hvidt V; Kromann-Andersen B; Nielsen KK; Linnet L; Metz P; Kirkeby HJ; Poulsen J
    Ugeskr Laeger; 1996 Jan; 158(2):176-7. PubMed ID: 8553493
    [No Abstract]   [Full Text] [Related]  

  • 16. [Written drug advertisements--are they reliable?].
    Solhaug HR; Indermo H; Slørdal L; Spigset O
    Tidsskr Nor Laegeforen; 2006 May; 126(10):1314-7. PubMed ID: 16691265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Marketing of inhalation steroids].
    As G
    Tidsskr Nor Laegeforen; 1994 Dec; 114(30):3703. PubMed ID: 7825154
    [No Abstract]   [Full Text] [Related]  

  • 18. [New neuroleptics--better effects or better marketing?].
    Lindefors N
    Lakartidningen; 2001 Oct; 98(41):4469. PubMed ID: 11699254
    [No Abstract]   [Full Text] [Related]  

  • 19. [Misleading marketing of the use of antibiotics].
    Sörberg M; Forsum U
    Lakartidningen; 1996 Oct; 93(41):3553-4. PubMed ID: 8965508
    [No Abstract]   [Full Text] [Related]  

  • 20. [Is deficient marketing also unfortunate?].
    Farup PG
    Tidsskr Nor Laegeforen; 2001 Mar; 121(9):1157-8. PubMed ID: 11354904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.